1. Home
  2. CSWC vs OGN Comparison

CSWC vs OGN Comparison

Compare CSWC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

HOLD

Current Price

$22.03

Market Cap

1.3B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$5.89

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSWC
OGN
Founded
1961
1923
Country
United States
United States
Employees
30
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CSWC
OGN
Price
$22.03
$5.89
Analyst Decision
Buy
Hold
Analyst Count
5
4
Target Price
$23.50
$11.75
AVG Volume (30 Days)
570.5K
3.0M
Earning Date
05-13-2026
04-30-2026
Dividend Yield
11.92%
1.40%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$17.45
$0.42
Revenue Next Year
$10.26
$1.67
P/E Ratio
$12.65
$7.92
Revenue Growth
N/A
N/A
52 Week Low
$17.47
$5.69
52 Week High
$23.84
$14.76

Technical Indicators

Market Signals
Indicator
CSWC
OGN
Relative Strength Index (RSI) 49.47 32.97
Support Level $21.30 N/A
Resistance Level $23.19 $7.87
Average True Range (ATR) 0.47 0.23
MACD 0.02 0.01
Stochastic Oscillator 75.44 28.57

Price Performance

Historical Comparison
CSWC
OGN

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: